The global vulvodynia treatment market is poised for significant growth, with sales expected to rise from USD 6.7 billion in 2025 to USD 12.4 billion by 2035, reflecting a CAGR of 6.3% over the ...

AG Letitia James is yet again aiming to advance her political career at New Yorkers’ expense — by demanding hospitals violate ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine) ...

Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today ...

Algiax Pharmaceuticals, a company committed to developing innovative treatments for chronic neuropathic pain, has released ...

Guillain-Barre Syndrome has caused concern in Maharashtra with 163 suspected cases and five fatalities. This rare ...